Tekla World Healthcare Fund:THW

    Manage Alerts

    Overview

    As of 10/23/2020

     Share
    Price
    NAVPremium/
    Discount
    Current$14.32$14.101.56%
    52 Wk Avg$13.80$14.21-2.96%
    52 Wk High$15.02$15.322.59%
    52 Wk Low$8.76$10.50-17.97%
    Regular Distribution TypeManaged Distribution
    Distribution Rate9.78%
    Distribution Amount$0.1167
    Distribution FrequencyMonthly
    Past performance is no guarantee of future results.

    Basic Information

    Investment Objective

    To seek current income and long-term capital appreciation. The Trust's investment objective is a non-fundamental policy and may be changed by the Board of Trustees of the Trust upon 60 days' notice to Shareholders. For a more detailed description of the Trust's investment objective and policies see 'Additional Information about Investments and Investment Techniques' and 'Investment Restrictions' in the SAI. For a description of the risks that may be associated with an investment in the Trust, see the section of this prospectus entitled 'Risk Factors.'

    Capital Structure

    As of 10/23/2020

    Total Investment Exposure:$543.870M
    Total Common Assets:$423.870M
    Common Shares Outstanding:30,168,652
    Leverage

    As of 10/22/2020

    Preferred Share Assets:
    Total Debt (USD): $120.000M
    Regulatory Leverage (USD): $120.000M
    Effective Leverage (USD): $120.000M
    Effective Leverage (%): 22.06%
    Annual Expense Ratios

    As of 9/30/2020

      Per Common Share
    Management Fees1.29%
    Other Expenses:0.31%
    Baseline Expense: N/A
    Interest Expense:0.94%
    Total: 2.53%
    Fund Management

    Fund Sponsor
    Tekla Capital Management LLC

    Portfolio Managers
    Daniel R. Omstead

    Basics
    Category: Equity-Sector Equity
    Ticker: THW
    NAV Ticker: XTHWX
    Average Daily Volume (shares): 159,500
    Average Daily Volume (USD): $2.154M
    Inception Date: 6/26/2015
    Inception Share Price: $20.00
    Inception NAV: $19.06
    Tender Offer: No
    Term: No
    Fiscal Year End: September 30
    Third Party Links & Reports

    Distributions

    As of 10/23/2020

    Past performance is no guarantee of future results.
    Distribution History

    Enter declared start and end dates to display distribution history below. Income, Long Gain, Short Gain and ROC breakdowns will only be shown for the past year.

    Declared Date Payable Date Ex Date Distrib Amount Income Long Gain Short Gain ROC

    *Indicates a Special Distribution: A distribution disbursed in addition to the normal distributions paid out by the company.

    Key Information Regarding Distributions
    Avg. Earnings Per Share:
    As of 3/31/2020
    $0.0499
    Annualized Distribution Rate on NAV:
    As of 10/23/2020
    9.93%
    Total Return on NAV (12 months):
    As of 10/23/2020
    15.53%
    Avg. Portfolio Coupon:
    As of 10/23/2020
    3.83%
    Total % Portfolio Effectively Leveraged:
    As of 10/23/2020
    22.06%

    Pricing Information

    Premium/Discount Information
    Past performance is no guarantee of future results.
    Premium/Discount Information

    As of 10/23/2020

    PeriodAvg Discount
    6 Month0.80%
    1 Year-2.96%
    3 Year-5.80%
    5 Year-7.01%
    Z-Score

    As of 10/23/2020

    PeriodZStat
    3 Month0.87
    6 Month0.95
    1 Year1.08
    Pricing History
    Date NAV Premium / Discount

    Performance

    Calendar Year Total Returns

    As of 9/30/2020
    Category: Morningstar US CEF Sector Equity

    Past 20 Years

    Return YearPriceNAVCategory - PriceCategory - NAV
    YTD12.04%2.42%-12.49%-9.13%
    201932.96%25.87%26.64%22.38%
    2018-5.35%-1.84%-12.35%-9.96%
    201716.95%12.42%18.18%12.88%
    2016-10.41%-14.95%17.45%14.67%
    Past performance is no guarantee of future results.
    Annualized Total Returns

    Returns for periods less than one year are cumulative rather than annualized

    As of 9/30/2020
    Category: Morningstar US CEF Sector Equity

    Past performance is no guarantee of future results.

    Portfolio Characteristics

    Portfolio Characteristics
    Average Coupon:
    As of 10/23/2020
    3.83%
    Number of Holdings:
    As of 6/30/2020
    183
    Annual Portfolio Turnover:
    As of 9/30/2020
    55.17%
    Asset Allocation

    As of 6/30/2020 reported by Fund Sponsor

    Top Sectors

    As of 6/30/2020 reported by Fund Sponsor

    Sector%Portfolio
    Healthcare74.28%
    Defensive (Super Sector)74.28%
    Corporate (Super Sector)16.58%
    Corporate Bond15.46%
    Real Estate4.64%
    Cyclical (Super Sector)4.64%
    Cash Equivalents (Super Sector)4.45%
    Cash Equivalents4.45%
    Preferred Stock1.13%
    Future Forward0.04%
    Top Holdings

    As of 6/30/2020 reported by Fund Sponsor

    HoldingValue% Portfolio
    Johnson & Johnson$30.53M5.62%
    Roche Holding AG ADR$18.74M3.45%
    UnitedHealth Group Inc$18.03M3.32%
    Merck & Co Inc$16.31M3.00%
    Novartis AG ADR$14.94M2.75%
    AstraZeneca PLC ADR$12.42M2.28%
    Bristol-Myers Squibb Company$12.27M2.26%
    Medtronic PLC$11.89M2.19%
    Pfizer Inc$11.49M2.11%
    AbbVie Inc$11.29M2.08%
    Credit Quality

    As of 6/30/2020 reported by Fund Sponsor

    Maturity Breakdown

    As of 6/30/2020 reported by Fund Sponsor

    Closed-end fund historical distribution sources have included net investment income, realized gains, and return of capital. For more detailed information on the distributions of a specific fund, please visit the sponsor's website.

    NOTES:

    Distribution type sourced from Morningstar. In general, managed distributions may be sourced from net investment income, realized gains and return of capital. CEFConnect.com does not undertake to disclose specific information about closed-end fund distribution sources. For specific information about a fund's distribution sources, visit the fund sponsor's website.

    The following information applies to closed-end funds in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.

    EWB-1014244PR-E1119W